Axim Biotechnologies
(OTC) AXIM
Axim Biotechnologies Financials at a Glance
Market Cap
$2.17M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.05M
EPS (TTM)
$-0.00
P/E Ratio
-1.79
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$0.01
Volume
301,126
Open
$0.01
Price
$0.01
Volume
301,126
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.03
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$0.01
Volume
301,126
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.03
AXIM News
AXIM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Axim Biotechnologies
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
John W. Huemoeller, II
Website
www.aximbiotech.comHeadquarters
San Diego, CA 92121, US
AXIM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
45%
Return on Assets
-33%
Earnings Yield
-55.87%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.17M
Shares Outstanding
355.63M
Volume
301.13K
Short Interest
0.00%
Avg. Volume
327.49K
Financials (TTM)
Gross Profit
$369.27K
Operating Income
$1.76M
EBITDA
$2.44M
Operating Cash Flow
$855.06K
Capital Expenditure
$2.84K
Free Cash Flow
$857.90K
Cash & ST Invst.
$245.00
Total Debt
$6.64M
Axim Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$108.13K
-787.2%
Gross Margin
0.00%
N/A
Market Cap
$2.17M
N/A
Market Cap/Employee
$361.55K
N/A
Employees
6
N/A
Net Income
$135.92K
+106.0%
EBITDA
$328.35K
+117.1%
Quarterly Fundamentals
Net Cash
$7.54M
-17.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.44M
+17.9%
Short Term Debt
$101.55K
-45.2%
Return on Assets
-32.53%
N/A
Return on Invested Capital
45.31%
N/A
Free Cash Flow
$673.59K
-221.8%
Operating Cash Flow
$673.59K
-221.8%